http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e78950b93e649afe46187db15fc155b3
Outgoing Links
Predicate | Object |
---|---|
family-name | Park |
name | Jong-Wan Park |
given-name | Jong-Wan |
organization-name | Department of Physical and Rehabilitation Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. Department of Pharmacology, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea; Ischemic/Hypoxic Disease Institute and Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea 1Department of Biomedical Science, BK21-plus Education Program, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, Korea.; 2Department of Pharmacology, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, Korea.; 3Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Daehak-ro, Jongno-gu, Seoul, Korea. Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Pharmacology, Seoul National University College of Medicine, Seoul, Republic of Korea; Ischemic/Hypoxic Disease Institute and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea Department of Pharmacology and Heart Research Institute, College of Medicine, Seoul National University, Seoul 110-799, Korea Departments ofPharmacology, Department of Biomedical Sciences; Ischemic/Hypoxic Disease Institute Department of Pharmacology, Seoul National University College of Medicine, Seoul 110-799, Korea.; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 110-799, Korea. Department of Pharmacology and Biomedical Science, Ischemic/Hypoxic Disease Institute, and Obstructive Upper Airway Research (OUaR) Laboratory, Department of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea; Department of Biomedical Science, Seoul National University Graduate School, Seoul 03080, Korea; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea 14Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea. Department of Pharmacology, Seoul National University College of Medicine Seoul 03080, South Korea. Department of Pharmacology, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 110-799, Korea. Department of Biomedical Science, BK21-Plus Education Program, Seoul National University College of Medicine, Jongno-gu, Seoul 03080, Republic of Korea; Department of Pharmacology, Seoul National University College of Medicine, Jongno-gu, Seoul 03080, Republic of Korea; Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Jongno-gu, Seoul 03080, Republic of Korea 2Pharmacology and 1Pharmacology and Departments of Department of Biomedical Science, Seoul National University College of Medicine, Seoul, 110-799, Republic of Korea; Department of Pharmacology, Seoul National University College of Medicine, Seoul, 110-799, Republic of Korea; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, 110-799, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, 110-799, Republic of Korea Authors' Affiliation: Departments of Pharmacology and Biomedical Science, Ischemic/Hypoxic Disease Institute, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea Department of Pharmacology, College of Medicine, Seoul National University, Seoul 03080, South Korea Authors' Affiliations: Departments of 1Pharmacology, 2Physiology, and 3Internal Medicine, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea Department of 2Pharmacology, Seoul National University College of Medicine,; Ischemia/Hypoxia Disease Institute, and From the Department of Pharmacology and Heart Research Institute, BK21 Human Life Sciences, Seoul National University College of Medicine, Chongno-gu, Seoul, Korea. Department of Pharmacology Department of Pharmacology, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea From the Department of Pharmacology and the Department of Physiology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; and the Laboratory of Human Carcinogenesis, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD. Obstructive Upper airway Research (OUaR) Laboratory, Department of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea. 1Pharmacology and Departments of; 3Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea, and Division of Hematology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA Department of Pharmacology and Heart Research Institute, BK21 Human Life Sciences, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-799, Korea |
Incoming Links
Total number of triples: 197.